Luca Antonioli Selected Research

2,4-dinitrobenzene

8/2022	Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis.
1/2020	The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luca Antonioli Research Topics

Disease

38	Inflammation (Inflammations) 08/2022 - 02/2006
14	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022 - 04/2008
14	Colitis 08/2022 - 02/2006
10	Obesity 10/2021 - 11/2017
10	Neoplasms (Cancer) 01/2021 - 12/2013
6	Pain (Aches) 01/2020 - 01/2006
5	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 01/2019
5	Crohn Disease (Crohn's Disease) 05/2020 - 04/2017
4	Body Weight (Weight, Body) 08/2022 - 08/2007
4	Ulcerative Colitis 02/2021 - 04/2017
4	Sepsis (Septicemia) 01/2019 - 06/2012
4	Wounds and Injuries (Trauma) 12/2017 - 07/2005
3	Ischemia 01/2021 - 12/2008
3	Rheumatoid Arthritis 11/2020 - 06/2012
3	Multiple Sclerosis 11/2020 - 01/2019
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2015
3	Ulcer 07/2012 - 03/2009
3	Stomach Ulcer (Gastric Ulcer) 07/2012 - 03/2009
2	Insulin Resistance 08/2022 - 01/2020
2	Weight Loss (Weight Reduction) 08/2022 - 01/2020
2	Hypertension (High Blood Pressure) 08/2022 - 01/2021
2	Morbid Obesity 08/2022 - 01/2020
2	Infections 05/2022 - 01/2019
2	Cognitive Dysfunction 12/2021 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2019
2	Atherosclerosis 01/2021 - 11/2020
2	Neuroinflammatory Diseases 06/2019 - 01/2019
2	Parkinson Disease (Parkinson's Disease) 06/2019 - 02/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 01/2019
2	Vomiting 10/2016 - 09/2010
2	Hemorrhage 02/2016 - 06/2009
2	Drug-Related Side Effects and Adverse Reactions 03/2014 - 10/2011
2	Peptic Ulcer (Peptic Ulcers) 02/2009 - 01/2008
1	Overweight 03/2022

Drug/Important Bio-Agent (IBA)

21	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 02/2006
12	2,4-dinitrobenzenesulfonic acidIBA 06/2021 - 02/2006
10	InflammasomesIBA 08/2022 - 01/2017
9	2,4-dinitrofluorobenzene sulfonic acidIBA 08/2022 - 06/2006
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2016
8	CytokinesIBA 05/2020 - 08/2007
8	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 07/2005
6	Pharmaceutical PreparationsIBA 06/2021 - 02/2006
6	NucleotidesIBA 01/2021 - 01/2017
6	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2020 - 04/2008
5	Biomarkers (Surrogate Marker)IBA 10/2022 - 02/2016
5	Dexamethasone (Maxidex)FDA LinkGeneric 06/2021 - 08/2007
5	Leucine (L-Leucine)FDA Link 01/2021 - 01/2017
5	EnzymesIBA 01/2021 - 04/2008
5	Adenosine Triphosphate (ATP)IBA 01/2021 - 12/2008
4	vedolizumabIBA 10/2022 - 01/2020
4	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 04/2015
4	Monoclonal AntibodiesIBA 05/2020 - 01/2010
4	Purinergic Receptors (Receptors, Purine)IBA 01/2019 - 04/2008
3	Oncostatin MIBA 10/2022 - 01/2020
3	Infliximab (Remicade)FDA Link 10/2022 - 01/2020
3	NucleosidesIBA 01/2021 - 03/2016
3	CollagenIBA 01/2020 - 01/2015
3	Biological ProductsIBA 08/2019 - 01/2017
3	Cholinergic Agents (Cholinergics)IBA 02/2016 - 02/2006
3	Protein Isoforms (Isoforms)IBA 07/2012 - 01/2006
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2012 - 01/2006
3	Adenosine DeaminaseIBA 06/2012 - 08/2007
2	Purinergic P2X4 ReceptorsIBA 08/2022 - 01/2019
2	2,4-dinitrobenzeneIBA 08/2022 - 01/2020
2	Sulfonic AcidsIBA 08/2022 - 01/2020
2	Caspase 1 (ICE Protease)IBA 08/2022 - 01/2018
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2022 - 02/2006
2	CholesterolIBA 10/2021 - 03/2014
2	LipidsIBA 01/2021 - 02/2016
2	Immunomodulating AgentsIBA 11/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 05/2020 - 11/2010
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 05/2020 - 01/2020
2	InterleukinsIBA 01/2020 - 01/2019
2	FlavonoidsIBA 12/2018 - 01/2018
2	AntioxidantsIBA 12/2018 - 01/2018
2	Diclofenac (SR 38)FDA LinkGeneric 01/2018 - 07/2005
2	Malondialdehyde (Propanedial)IBA 02/2016 - 03/2009
2	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateIBA 09/2015 - 01/2014
2	Indomethacin (Indometacin)FDA LinkGeneric 07/2012 - 03/2009
2	Caspase 3 (Caspase-3)IBA 07/2012 - 03/2009
2	SC 560IBA 07/2012 - 06/2006
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2012 - 03/2009
2	Acetic Acid (Vinegar)FDA LinkGeneric 07/2012 - 03/2009
2	VaccinesIBA 01/2012 - 04/2011
2	AcidsIBA 01/2011 - 03/2009
2	Proton Pump InhibitorsIBA 01/2011 - 03/2009
2	pyrazoleIBA 11/2010 - 08/2007
2	pyrimidineIBA 11/2010 - 08/2007
2	9-(2-hydroxy-3-nonyl)adenine (EHNA)IBA 11/2010 - 08/2007
2	Paroxetine (Paxil)FDA LinkGeneric 07/2010 - 06/2009
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2006 - 03/2005
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2006 - 03/2005
1	NP-1815-PXIBA 08/2022
1	OccludinIBA 08/2022

Therapy/Procedure

6	Therapeutics 05/2022 - 02/2016
2	Bariatric Surgery 08/2022 - 01/2020
2	Biological Therapy 12/2019 - 02/2016
2	Immunotherapy 11/2017 - 02/2016
2	Drug Therapy (Chemotherapy) 11/2017 - 04/2008
1	Length of Stay 03/2022